LiverHealthPOD LiverHealthPOD

One of the most talked about medication in the world at the moment - Semaglutide (also known as Ozempic or Wegovy) is a class of medicines called GLP-1 receptor agonist. Developed for diabetes but now frequently being used to aid weight loss amongst other things.

Does Semaglutide has a roll in management of the most common liver disease - Fatty Liver? Find out in this discussion.

If you like the POD don't forget to leave a rating and hit subscribe so tyou don't miss an episode. You can also follow us on socials @LiverHealthPOD.

In this episode Will, John and Paul discuss functions of the liver that you may not have thought about. We move well beyond detoxification and making bile to coagulation, circadian rhythms and blood glucose levels

We hope you enjoy this episode and don't forget to support the podcast following to show. Send us a note of the socials or leave us a rating if you like.

Thanks for listening.

In this episode Paul, Will and John have a discussion about liver cysts. up to 1 in 10 people have liver cysts. Do you? Find out if it matters.

Don't forget top like and subscribe to support the podcast and if you're feeling up to it - leave us a rating.

Thanks for listening.

In this episode Paul, John and Will discuss the benefits of exercise on the liver. Anaerobic, aerobic, HIIT - Which is best. Listen in to the thoughts of the LiverHealthPOD.

In this episode Paul, John and Will have a conversation about Primary Sclerosing Cholangitis (PSC). What does it mean to have this condition that continues to baffle medical science.

What's all the buzz around resistant starch. What is it? what does it do? where do you find it? is it worth the trouble. Find out about the evidence for resistant starch and whether it may be good for you?

In this episode Will, John and Paul unpack the data for resistant starch.